AOD 9604

What is AOD 9604? AOD 9604 (Advanced Obesity Drug 9604) is a modified synthetic peptide consisting of amino acids 176-191 from the C-terminal region of human growth hormone (hGH). Developed by Metabolic Pharmaceuticals in Australia, it was specifically designed to retain the fat-burning effects of growth hormone while eliminating effects on insulin sensitivity, blood sugar regulation, and cell proliferation that can occur with full-length hGH.